If Jason n ' s revenue predictions on lympro are accurate in the chart anaconda posted were in trouble I really don't see any partner/buyout on horizon. It just doesn't add up what are we missing that a diagnostic that saves BP millions is only projected to grab Less than 1 percent of a 150 million RUO market in 2015??